AI assistant
TECOGEN INC. — Director's Dealing 2025
Jun 24, 2025
33623_dirs_2025-06-24_efe0b3f1-00fa-4e16-9418-8ebc9a351794.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECOGEN INC. (TGEN)
CIK: 0001537435
Period of Report: 2025-03-03
Reporting Person: Lafaille Stephen (VP of Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | P | 400 | $2.50 | Acquired | 400 | Direct |
| 2025-06-03 | Common Stock | X | 10000 | $0.71 | Acquired | 10400 | Direct |
| 2025-06-03 | Common Stock | S | 10000 | $4.88 | Disposed | 400 | Direct |
| 2025-06-04 | Common Stock | X | 15000 | $0.71 | Acquired | 15400 | Direct |
| 2025-06-04 | Common Stock | S | 15000 | $5 | Disposed | 400 | Direct |
| 2025-06-06 | Common Stock | X | 25000 | $1.10 | Acquired | 25400 | Direct |
| 2025-06-06 | Common Stock | S | 25000 | $5.98 | Disposed | 400 | Direct |
| 2025-06-23 | Common Stock | X | 10000 | $1.10 | Acquired | 10400 | Direct |
| 2025-06-23 | Common Stock | S | 10000 | $7.25 | Disposed | 400 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-03 | Stock Options (Right to Buy) | $0.71 | X | 10000 | Disposed | 2030-07-09 | Common Stock (50000) | Direct |
| 2025-06-04 | Stock Options (Right to Buy) | $0.71 | X | 15000 | Disposed | 2030-07-09 | Common Stock (40000) | Direct |
| 2025-06-06 | Stock Options (Right to Buy) | $1.10 | X | 25000 | Disposed | 2032-01-21 | Common Stock (52500) | Direct |
| 2025-06-23 | Stock Options (Right to Buy) | $1.10 | X | 10000 | Disposed | 2032-01-21 | Common Stock (25000) | Direct |
Footnotes
F1: Shares acquired pursuant to exercise of Stock Option Agreement dated 7/9/2020
F2: Multiple share sales between $4.75 and $5.25 per share
F3: 10,000 shares sold for $4.90 per share, and 5,000 shares sold for $5.10 per share
F4: Shares acquired pursuant to stock option agreement dated 1/21/2022
F5: Multiple share sales between $5.85 and $6.10
F6: Vests 50% upon achievement of Adjusted EBITDA goal of 2% of revenue in two consecutive quarters, and 50% upon achievement of Adjusted EBITDA goal of 3% of revenue in four consecutive quarters
F7: Vests 50% per year